
New abilities in therapy of idiopathic pulmonary fibrosis
Author(s) -
С. Н. Авдеев
Publication year - 2017
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 6
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2017-27-4-502-514
Subject(s) - nintedanib , medicine , idiopathic pulmonary fibrosis , adverse effect , interstitial lung disease , placebo , dlco , lung , pathology , lung function , diffusing capacity , alternative medicine